Caffeine is a highly consumed stimulant of the nervous system. Although caffeine has diverse effects on different brain functions, little is known about the specific pharmacokinetics of this substance in the brain. For instance, most studies that assessed caffeine distribution in the rat brain have only measured caffeine levels in the cortex and striatum but not in more specific brain areas.Aims: The purpose of this work was to measure the caffeine concentration in blood and different brain regions (i.e. cortex, striatum, hippocampus, cerebellum and brainstem) at different times after the administration of a single intraperitoneal dose of caffeine.Methods: Adult Wistar rats (250 to 300 gr) were injected with a single intraperitoneal dose of 30 mg/ Kg of caffeine. 20, 40, 60 and 80 minutes after administration, subjects were sacrificed by decapitation and samples of plasma, cerebral cortex, striatum, hippocampus, cerebellum and brainstem were obtained. Caffeine levels in the blood and each brain structure were 
measured by RP-HPLC and statistical analysis was performed. Results: Caffeine levels were higher in the plasma compared to all the brain structures studied. Different brain regions displayed similar caffeine concentrations. For all brain regions, the maximal concentration levels of caffeine were reached in the first 40 minutes after caffeine administration.Conclusions: The results support previous studies that show similar caffeine concentration between cortex and striatum, but also extend the results to other brain structures. Furthermore, caffeine concentration increases similarly in the plasma and brain structures. 40, 60 and 80 minutes after administration, caffeine concentration in the blood is almost two times higher than in the brain. This suggests that the effects of caffeine on different brain functions do not depend on pharmacokinetic differences between brain areas and are rather explained by pharmacodynamics. 
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INTRODUCTION
Caffeine has important effects on different brain functions such as motor behavior, attention, memory and learning (1-6). Caffeine acts on dopamine, GABA, NMDA and Ryanodine receptors (7) (8) (9) (10) , and as a competitive antagonist of adenosine receptors (2, 10) . The differential effects of caffeine on behavior and cognition are thought to depend on its specificity for different receptor types (10) . Since different brain regions have different number, composition and combinations of neurotransmitter receptors, the effects of caffeine on the central nervous system (CNS) are thought to be explained mainly by pharmacodynamic mechanisms (8, 10) .
However, the effects of caffeine can still depend on pharmacokinetic mechanisms, as differential effects of caffeine have been described according to the administered dose; for example, low doses (2.5 mg/Kg) in rats activate dopaminergic circuits involved in locomotor behavior, while higher doses (10 mg/Kg) affect pathways and structures responsible for reward and pleasure (11) . Similarly, acute administration of caffeine impairs learning (12) , whereas chronic intake during adulthood may prevent memory decline (13) . Thus, while these distinct effects of caffeine on different brain functions and regions could be explained by the differential distribution of neurotransmitter receptors involved in specific brain circuits (14, 15) , differences in caffeine
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The early kinetics of caffeine between different brain structures is not well known; whereas most studies compare caffeine levels in the brain compared to plasma, few studies have explored the distribution of caffeine across structures of the CNS. In those cases, the comparison is made between cortical and subcortical regions; for instance, Carey and De Palma (16) found higher caffeine concentrations in the cerebral cortex compared to the striatum, while Ferré et al. (17) found opposite results. Moreover, the patterns of caffeine distribution in the hippocampus and cerebellum, regions important for memory and motor behavior, respectively, have not been studied.
In this study, we determined the relationships between caffeine concentration in the plasma and different brain structures, including the cerebral cortex, hippocampus, striatum, cerebellum and brainstem 20, 40, 60 and 80 minutes after the administration of a single dose of caffeine. Caffeine concentration was higher in plasma than in all the brain structures studied at 40, 60 at 80 minutes. We did not find significant differences in caffeine levels between the brain structures studied. These results suggest that the pharmacological effects of caffeine on different brain and cognitive functions are not influenced by pharmacokinetic differences between brain areas.
MATERIALS AND METHODS
Animals: 25 Adult Wistar rats (250 to 300 gr) were kept in the animal facility under standard conditions. We followed the National Institutes of Health (NIH) guidelines for the use of laboratory animals (18) Caffeine extraction: Caffeine was extracted using a solid-phase extraction column (SPE Cartridge C18, 1 ml, RESPREP-Restek®, Philadelphia). The column was conditioned with 1 ml methanol and 1 ml H 2 O, and the samples were loaded and allowed to drain by gravity; the columns were subsequently loaded with 1 ml H 2 O, and caffeine was finally eluted in 1ml methanol. The eluted samples were filtered using discs of regenerated cellulose (0.2 µm, 52225-RC, Titian) and kept in vials for reversed phase high performance liquid chromatography (RP-HPLC) quantification.
Blood samples were centrifuged for 10 minutes to isolate the plasma. Plasma samples were loaded into the SPE columns and processed as the brain samples.
Determination of caffeine concentration by RP-HPLC:
A LC-2010AHT Shimadzu-LC®liquid chromatography apparatus with an UV detector LC-2010 and aC18 Premier column (150 mm x 4.0 mm) were used. The mobile phase consisted of methanol (solvent A) and water (solvent B).
From the time of sample injection, a gradient of 30% of A and 70% of B was set up and held for 6 minutes, after which it finished with 100% of A. The flow rate was 1mL/minute. The wavelength of the detector was set at 278nm.
Validation method:
The caffeine standard was prepared by diluting 2 mg of caffeine in 1 ml of methanol. The peaks in the chromatogram were identified by comparison with the retention of the caffeine standard. The eluting peak of the caffeine was present between 3.7 min and 4.2 min (figure 1b).The calibration curve was constructed using dilutions of the caffeine standard in a 0.01-2.0 mg/ml-concentration range (figure 1a). 20 µl aliquots of each dilution were injected directly into the RP-HPLC. All injections were also performed in triplicate. The linear regression analysis for testing linearity was performed by plotting the area under the peaks against caffeine concentrations. 
RESULTS
Caffeine concentration is higher in the plasma compared to brain structures: After a single dose of 30 mg/Kg, we observed higher concentrations of caffeine in the plasma compared to the brain (p<0.01), at 40, 60 and 80 minutes. At these times, caffeine concentration in brain structures was about 50% of caffeine level in plasma. Furthermore, caffeine concentration in plasma did not show significant decline in the time range of the study (Figure 2) . Caffeine concentration is similar across brain structures: We did not find significant differences in caffeine concentration between the brain structures studied (Kruskal-Wallis p>0.05).
In brain structures, the maximal concentration of caffeine was reached in the first 40 minutes after caffeine administration (Table 1) . 
DISCUSSION
We studied the concentration of caffeine in different structures of the brain and plasma at different times after an intraperitoneal injection of 30mg/Kg of caffeine in rats. Our results are not expected to differ from those obtained by other methods of administration, such as oral or subcutaneous, because they show similar pharmacokinetic curves in plasma (8) . Furthermore, the selected dose is in accordance with previous studies (16, 17, 21, 23) .
Additional small peaks related to the caffeine metabolites theophylline and theobromine (24) were present in the chromatograms. However, as can be seen in Figure 1 , those peaks do not interfere with the identification of the caffeine peak, which was well separated in all samples. We focused our analysis on the caffeine peak.
Our results indicate that the concentration of caffeine in the plasma is higher compared to the brain structures studied during the first 80 minutes after caffeine administration; these results are consistent with those found by Carey and De Palma (16), Ståhle, Segersvärd (21) and opposite to those found by Ferré et al., (17) , who found higher caffeine levels in striatum and brain compared to plasma. Kaplan et al., (22) did not find differences in caffeine concentration between brain and plasma over a 4 h time period.
We did not observe differences in the caffeine concentration between the striatum and the cortex after a single dose of 30 mg/Kg. This finding is in disagreement with the results reported by Carey and De Palma (16) who found higher caffeine levels in cortex compared to striatum with doses of 10 and 50 mg/Kg, 40 minutes after administration. The results were also in disagreement with Ferré et al. (17) , who found higher levels of caffeine in the striatum than in the cortex between 5 and 25 h after caffeine administration. Nevertheless, our results and those reported by Stahle et al. (21) and Kaplan et al. (22) indicate that there are no differences in the levels of caffeine between different brain structures during the first 80 minutes after a single dose of caffeine is administered.
An important observation is the high intersubject variability at different times. Indeed, Mary Orrego Cardozo et al.
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However, the fact that we observed clear differences in the caffeine concentration between plasma and brain indicates that this HPLC-based method for caffeine quantification was sensitive enough and that the absence of differences between brain structures at the time-points studied is real. The present results suggest that the effects of caffeine on different behaviors cannot be explained by the differential distribution of caffeine (pharmacokinetics) in different brain regions and could be rather explained mainly by pharmacodynamic mechanisms, as suggested by Fredholm et al. (8) and Yoshimura (10) .
CONCLUSIONS
The present results indicate that the concentration of caffeine is higher in plasma compared to brain structures at 40, 60 and 80 minutes after caffeine administration; yet, caffeine appears to be homogeneously distributed across different brain regions during the first 80 minutes. These results suggest a non-linear relationship between the concentration of caffeine in the plasma and brain structures and also supports the hypothesis that pharmacokinetic mechanisms are insufficient to account for the diverse effects of caffeine in the brain.
